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Reactions between glucose and protein are held to be responsible for the protein ‘browning’ reactions which occur in diabetes mellitus. In vitro, 
however, the formation of such novel protein fluorophores is dependent upon the metal-catalysed oxidation of the monosaccharide (glucose ‘autoxi- 
dation’). Since other small oxidisable molecules are capable of ‘browning’ proteins via similar metal-catalysed oxidative mechanisms we suggest 
that protein modification in diabetes may not be restricted to reactions with monosaccharides but may also include other small autoxidisable mole- 
cules. 
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1. INTRODUCTION 
A number of metabolic abnormalities characterise 
diabetes, including altered lipid metabolism [ 1,2], 
ascorbic acid metabolism [3,4] and hyperglycaemia 
[4,5]. Elevated glucose levels are the most obvious 
feature of the diabetic individu~. As a result, the non- 
enzymic glycation theory of glucose toxicity, described 
in the first instance by food chemists, has often been us- 
ed as a potential explanation for the underlying tissue 
damage associated with diabetic complications [6,7]. 
Non-enzymic glycation, often studied in vitro by in- 
cubating protein with glucose 181 occurs via glucose 
condensation, Schiff’s base formation and rearrange- 
ment to form the Amadori product. Amadori products 
may subsequently degrade and lead to 
chromo/fluorophoric adducts and result in the protein 
becoming ‘browned’ and fluorescent [9]. 
We have demonstrated, however, that reactions be- 
tween glucose and proteins in vitro are considerably 
more complex than such simple addition of glucose to 
protein amino groups. Glucose can oxidise, catalysed 
by trace amounts of transition metal, under 
physiological conditions, generating hydrogen perox- 
ide, reactive oxidants, and keto~dehydes which con- 
tribute to protein fluorescence alterations and struc- 
tural damage [lo]. Indeed, in vitro at least, browning 
reactions appear to be largely inhibited if such oxidative 
reactions are suppressed. Since other small molecules 
such as ~l~nsaturated fatty acids and ascorbic acid 
are also implicated in diabetic tissue damage and are 
also subject to transition metal catalysed oxidation, we 
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have compared their protein oxidation and modifica- 
tion properties with those of glucose. 
2. MATERIALS AND METHODS 
2.1. Protein fragmentation 
Free radicals are known to fragment protein to trichloroacetic acid 
~CA)-soluble peptide [ 111. cY-Crystallin. prepared from homogenis- 
ed bovine lens using gel Eltration [ 121, was incubated with 25 mM 
glucose or ascorbate as described in legends to the figures. The pro- 
duction of TCA-soluble peptide was determined using the 
fluorescamine assay [13]. 150 4 samples of a 5% TCA-supernatant 
were added to 850 al of 0.5 M potassium phosphate buffer @H 6.8). 
This was then mixed with 1 ml fluorescamine solution (0.1 m&ml in 
acetone). Fluorescence was determined after an incubation of 20 min 
at room temperature at an excitation wavelength of 392 nm and emis- 
sion wavelength of 476 nm using a Perkin-Elmer LS 5 fluorometer. 
Protein standards of bovine serum albumin (BSA) between 0 and 100 
pg/ml were used to estimate protein concentration. Neither glucose 
nor ascorbic acid, at the concentration of 25 mM, interfered in this 
assay. 
2.2. ~eneratton of novet protgin fluorescence 
Protein (o-crystallin or BSA), previously exposed to ascorbic acid 
or glucose as described in legends to the figures, was precipitated and 
washed with 5010 trichloroacetic acid prior to resuspending in 100 mM 
potassium phosphate (pH 7.2). The suspension was fluorimetrically 
assessed by measuring emission between 350 nm and 500 nm when ex- 
citing at 350 nm [14]. In the case of arachidonic acid exposure, the 
protein was delipidated by the Folch-Lees method [If] prior to 
fluorimetric assessment. 
Incubations were performed using filter sterilised (0.25 p filter) 
reaction mixtures, except in the case of fatty acid incubations, in 
which 100 *g/ml penicillin and streptomycin were included. 
3. RESULTS AND DISCUSSIGN 
cr-Hydroxyaldehydes, such as glucose, can enolize 
and undergo a transition metal-catalysed oxidation 
under physiological conditions [ 14,161. This produces 
protein-reactive a-ketoaldehydes capable of browning 
proteins. The exposure of ar-crystal&r to glucose (Fig. 
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Fig. 1. The browning of o-crystallin by glucose and ascorbic acid. 5 
mg/ml o-crystallin was incubated at 37°C with 25 mM glucose or 
ascorbic acid in the presence of 100 mM potassium phosphate (pH 
7.2), for 1 and 14 days, respectively. After incubation, protein was 
washed free of unbound reagents by trichloroacetic acid precipitation 
and assessed fluorimetrically (Excitation 350 nm). Profile 1, protein 
and buffer; 2, protein and glucose or ascorbic acid; 3, protein, glucose 
or ascorbic acid, 50 mM glutathione (reduced); 4, proteins, glucose or 
ascorbic acid and 50 mM glutathione (oxidised); 5, proteins, glucose 
or ascorbic acid and 1 mM DETAPAC. 
la) leads to fluorophore formation which is inhibited 
by the addition of the metal chelator diethylene- 
triaminepenta-acetic acid, (DETAPAC), indicating the 
role of metal-catalysis during in vitro ‘browning’ of this 
particular protein by glucose. Ascorbic acid, a perma- 
nent enediol, is also able to undergo metal-catalysed ox- 
idation [l&20] and modify proteins [21-231 in a similar 
manner to glucose. DETAPAC also inhibited 
fluorophore formation in the case of ascorbic acid (Fig. 
lb). Both oxidised and reduced glutathione inhibited 
fluorophore formation. However, in the case of ascor- 
bic acid, reduced glutathione (which maintains ascorbic 
acid in the reduced state [24]) led to profound inhibition 
of fluorophore formation. In contrast, glucose- 
mediated fluorophore formation was inhibited to a 
lesser degree, and equally, by both oxidised and reduc- 
ed glutathione, suggesting that the amino groups rather 
than the thiol groups are important in the inhibition 
seen with glucose. Metal-catalysed oxidative reactions 
are thus required for both glucose- and ascorbate- 
mediated browning reactions. However, comparison of 
Fig. la and lb demonstrates that fluorophore genera- 
tion by ascorbic acid (performed over 1 day) far exceed- 
ed that of glucose (performed over 14 days). 
Concomitant with this generation of protein 
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Fig. 2. The exposure of cY-crystallin to ascorbic acid and glucose leads 
to the production of trichloroacetic acid-soluble peptide. 5 mg/ml (Y- 
crystallin was incubated as described in the legend to Fig. 1. Exposure 
to ascorbic acid or glucose over 1 and 14 days, respectively, leads to 
protein fragmentation to trichloroacetic acid-soluble fluorescamine- 
reactive peptide. 
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Fig. 3. A number of small autoxidisable molecules lead to protein 
browning. 5 mg/ml bovine serum albumin was exposed to 25 mM 
ascorbic acid, arachidonic acid (2 days) or glucose (7 days) in the 
presence of 100 mM potassium phosphate @H 7.2). Reactions were 
performed in the presence or absence of 1 mM DETAPAC. The pro- 
tein was then assessed fluorimetrically (Excitation 350 nm). Profile 1, 
protein and buffer; 2, protein and glucose; 3, protein and ascorbic 
acid; 4, protein and arachidonic acid. INSET: Percentage inhibition 
of fluorophore formation by 1 mM DETAPAC of the maximal emis- 
sion wavelength. 
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fluorophores during the reactions of ascorbic acid and 
glucose with protein, the protein undergoes free radical- 
mediated fragmentation to TCA-soluble peptides 
[14,16,17] (Fig. 2). Fragmentation by both glucose and 
ascorbic acid was inhibited by the inclusion of 1 mM 
DETAPAC. The control reaction mixture, consisting 
of protein and buffer, contained ca 0.4% TCA-soluble 
peptide which did not change with time. 
REFERENCES 
111 
121 
[31 
Beviacqua, S., Buzzigoli, G., Bonadonna, R., Brandi, L., 
Oleginni, T., Boni, C., Geloni, M. and Ferrannini, E. (1990) 
Diabetes 39, 383-389. 
Waitzmann, M.B. (1979) Metabolism. 28,401~406. 
Som, S., Basu, D., Mukherjee, S., Deb, S., Choudhary, P.R., 
Mukherjee, S.N. and Chatterjee, I. (1981) Metabolism. 30, 
572-577. 
Thus, in Figs 1 and 2, we have demonstrated that 
browning reactions mediated by glucose are less exten- 
sive than those mediated by ascorbic acid, and that 
modification reactions by ascorbate as well as glucose 
are associated with free radical damage to the protein. 
[41 
r51 
Finally, we have also demonstrated that exposure of 
bovine serum albumin to pol~nsaturated fatty acids, 
such as arachidonic acid, is also able to generate protein 
fluorophores (Fig. 3) and that this process is also in- 
hibited by DETAPAC (Fig. 3 inset). Fig. 3 also shows 
the similarity in fluorescence characteristics for the 
three protein modifying agents studied. Other studies 
have shown that unsaturated lipids also produce protein 
fragmenting oxidants, as a result of their metal- 
catalysed oxidation [ 11,251. 
161 
[71 
181 
[91 
[lOI 
Our investigations suggest that the reaction of 
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tein modification in diabetes and imply that oxidative 
reactions are commonly involved. Indeed, both ascor- 
bic acid and arachidonic acid are able to oxidise and 
brown proteins. Perhaps their involvement in metal- 
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idation of small molecules such as glucose during in 
vitro exposure of protein to such molecules and ques- 
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